Kevin Chou
Examiner (ID: 9940)
Most Active Art Unit | 3785 |
Art Unit(s) | 3785 |
Total Applications | 4 |
Issued Applications | 0 |
Pending Applications | 0 |
Abandoned Applications | 4 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16571077
[patent_doc_number] => 20210010083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => TEMPORAL PEDIATRIC SEPSIS BIOMARKER RISK MODEL
[patent_app_type] => utility
[patent_app_number] => 16/948556
[patent_app_country] => US
[patent_app_date] => 2020-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11753
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 302
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16948556
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/948556 | TEMPORAL PEDIATRIC SEPSIS BIOMARKER RISK MODEL | Sep 22, 2020 | Abandoned |
Array
(
[id] => 17274514
[patent_doc_number] => 20210380712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => TARGETING METASTASIS STEM CELLS THROUGH A FATTY ACID RECEPTOR (CD36)
[patent_app_type] => utility
[patent_app_number] => 17/021894
[patent_app_country] => US
[patent_app_date] => 2020-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17021894
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/021894 | TARGETING METASTASIS STEM CELLS THROUGH A FATTY ACID RECEPTOR (CD36) | Sep 14, 2020 | Pending |
Array
(
[id] => 17399665
[patent_doc_number] => 20220041755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => ANTI-BIOTIN ANTIBODY AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/436744
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436744
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/436744 | Anti-biotin antibody and application thereof | Sep 3, 2020 | Issued |
Array
(
[id] => 16526455
[patent_doc_number] => 20200400535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => IN SITU HEAT INDUCED ANTIGEN RECOVERY AND STAINING APPARATUS AND METHOD
[patent_app_type] => utility
[patent_app_number] => 17/011397
[patent_app_country] => US
[patent_app_date] => 2020-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17011397
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/011397 | In situ heat induced antigen recovery and staining apparatus and method | Sep 2, 2020 | Issued |
Array
(
[id] => 17400908
[patent_doc_number] => 20220042998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => BIOMARKERS FOR PANCREATIC CANCER
[patent_app_type] => utility
[patent_app_number] => 17/003139
[patent_app_country] => US
[patent_app_date] => 2020-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15332
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17003139
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/003139 | Biomarkers for pancreatic cancer | Aug 25, 2020 | Issued |
Array
(
[id] => 16933777
[patent_doc_number] => 20210199666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => SPR-BASED BRIDGING ASSAY FORMAT FOR DETERMINING THE BIOLOGICAL ACTIVITY OF MULTIVALENT, MULTISPECIFIC MOLECULES
[patent_app_type] => utility
[patent_app_number] => 16/998990
[patent_app_country] => US
[patent_app_date] => 2020-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16998990
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/998990 | SPR-BASED BRIDGING ASSAY FORMAT FOR DETERMINING THE BIOLOGICAL ACTIVITY OF MULTIVALENT, MULTISPECIFIC MOLECULES | Aug 19, 2020 | Abandoned |
Array
(
[id] => 18590272
[patent_doc_number] => 11739155
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Antibodies that bind to AXL proteins
[patent_app_type] => utility
[patent_app_number] => 16/987118
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 39
[patent_no_of_words] => 21212
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16987118
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/987118 | Antibodies that bind to AXL proteins | Aug 5, 2020 | Issued |
Array
(
[id] => 18545337
[patent_doc_number] => 11718677
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Antibodies that bind to AXL proteins
[patent_app_type] => utility
[patent_app_number] => 16/987100
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 39
[patent_no_of_words] => 21011
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16987100
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/987100 | Antibodies that bind to AXL proteins | Aug 5, 2020 | Issued |
Array
(
[id] => 16622774
[patent_doc_number] => 20210041427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => METHODS AND COMPOSITIONS FOR PHOTOTRANSFER
[patent_app_type] => utility
[patent_app_number] => 16/937284
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 133672
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16937284
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/937284 | METHODS AND COMPOSITIONS FOR PHOTOTRANSFER | Jul 22, 2020 | Abandoned |
Array
(
[id] => 16674644
[patent_doc_number] => 20210063407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => METHOD FOR SCREENING PERSONALIZED INTESTINAL ENVIRONMENT-IMPROVING MATERIAL AND COMPOSITION THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/932626
[patent_app_country] => US
[patent_app_date] => 2020-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16932626
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/932626 | Method for screening personalized intestinal environment-improving material and composition therefor | Jul 16, 2020 | Issued |
Array
(
[id] => 16514210
[patent_doc_number] => 20200393468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => METHOD FOR PREDICTING CANCER SENSITIVITY
[patent_app_type] => utility
[patent_app_number] => 16/912087
[patent_app_country] => US
[patent_app_date] => 2020-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18919
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16912087
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/912087 | Method for predicting cancer sensitivity | Jun 24, 2020 | Issued |
Array
(
[id] => 16312611
[patent_doc_number] => 20200291349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => METHODS FOR IMPROVEMENT OF SEMEN QUALITY
[patent_app_type] => utility
[patent_app_number] => 16/887142
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16887142
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/887142 | METHODS FOR IMPROVEMENT OF SEMEN QUALITY | May 28, 2020 | Abandoned |
Array
(
[id] => 16239642
[patent_doc_number] => 20200256876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => KIT FOR IN VITRO OR EX VIVO MEASUREMENT OF THE EXPRESSION OF sCD127 IN A BIOLOGICAL SAMPLE
[patent_app_type] => utility
[patent_app_number] => 16/860333
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6547
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16860333
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/860333 | KIT FOR IN VITRO OR EX VIVO MEASUREMENT OF THE EXPRESSION OF sCD127 IN A BIOLOGICAL SAMPLE | Apr 27, 2020 | Abandoned |
Array
(
[id] => 16313796
[patent_doc_number] => 20200292534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => ACTIVATION OF BIOLUMINESCENCE BY STRUCTURAL COMPLEMENTATION
[patent_app_type] => utility
[patent_app_number] => 16/851841
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16851841
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/851841 | Activation of bioluminescene by structural complementation | Apr 16, 2020 | Issued |
Array
(
[id] => 17400794
[patent_doc_number] => 20220042884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => DEVICES AND METHODS FOR TISSUE AND CELL STAINING (II)
[patent_app_type] => utility
[patent_app_number] => 17/422444
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422444
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/422444 | DEVICES AND METHODS FOR TISSUE AND CELL STAINING (II) | Feb 18, 2020 | Pending |
Array
(
[id] => 16454001
[patent_doc_number] => 20200363427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => DEVICE AND METHOD FOR DETECTION OF ANALYTES
[patent_app_type] => utility
[patent_app_number] => 16/750807
[patent_app_country] => US
[patent_app_date] => 2020-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16750807
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/750807 | Device and method for detection of analytes | Jan 22, 2020 | Issued |
Array
(
[id] => 16680725
[patent_doc_number] => 10940181
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Combined preparations for the treatment of cancer or infection
[patent_app_type] => utility
[patent_app_number] => 16/733829
[patent_app_country] => US
[patent_app_date] => 2020-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 19072
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16733829
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/733829 | Combined preparations for the treatment of cancer or infection | Jan 2, 2020 | Issued |
Array
(
[id] => 17776612
[patent_doc_number] => 20220242961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => ANTI-4-1BB ANTIBODY AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/296752
[patent_app_country] => US
[patent_app_date] => 2019-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15036
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296752
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/296752 | ANTI-4-1BB ANTIBODY AND USE THEREOF | Dec 1, 2019 | Pending |
Array
(
[id] => 16178263
[patent_doc_number] => 20200225231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => AFFINITY-BASED DETECTION OF LIGAND-ENCODED SYNTHETIC BIOMARKERS
[patent_app_type] => utility
[patent_app_number] => 16/691788
[patent_app_country] => US
[patent_app_date] => 2019-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27785
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16691788
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/691788 | Affinity-based detection of ligand-encoded synthetic biomarkers | Nov 21, 2019 | Issued |
Array
(
[id] => 18328247
[patent_doc_number] => 11633464
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Cancer prevention and therapy by inhibiting soluble tumor necrosis factor
[patent_app_type] => utility
[patent_app_number] => 16/688930
[patent_app_country] => US
[patent_app_date] => 2019-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 31
[patent_no_of_words] => 28128
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16688930
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/688930 | Cancer prevention and therapy by inhibiting soluble tumor necrosis factor | Nov 18, 2019 | Issued |